Literature DB >> 16151903

High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease.

A C Hauser1, A Gessl, M Lorenz, T Voigtländer, M Födinger, G Sunder-Plassmann.   

Abstract

Anderson-Fabry disease is a rare lysosomal storage disorder. It results from a deficiency of the lysosomal alpha-galactosidase A and leads to progressive accumulation of globotriaosylceramide in the endothelium and tissue cells of various organs. Some of the typical clinical findings such as tiredness, dry skin, myalgia and arthralgia as well as vague gastrointestinal complaints are also symptoms of hypothyroidism. Therefore, we studied the thyroid function in patients with Anderson-Fabry disease. Thyroid function was studied in 11 patients (6 female, 5 male) with Anderson-Fabry disease by measuring thyroid-stimulating hormone (TSH) and free thyroxine serum levels. Nine patients had chronic kidney disease with stage 1 and two with stage 5. Subclinical hypothyroidism (normal serum free thyroxine concentrations along with elevated serum TSH levels) was found in 4 of 11 patients (36.4%). Subclinical hypothyroidism was observed in both male and female patients as well as in patients with stage 1 and stage 5 kidney disease. Subclinical hypothyroidism is a common finding in patients with Anderson-Fabry disease, showing an excess prevalence as compared to the normal population. The high frequency seems to be relevant regarding the potential consequences of a hypothyroid state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151903     DOI: 10.1007/s10545-005-0003-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  45 in total

1.  Reversible increase of intraocular pressure in subclinical hypothyroid patients.

Authors:  M Centanni; R Cesareo; O Verallo; M Brinelli; G Canettieri; N Viceconti; M Andreoli
Journal:  Eur J Endocrinol       Date:  1997-06       Impact factor: 6.664

Review 2.  Natural history and treatment of renal involvement in Fabry disease.

Authors:  Mary Branton; Raphael Schiffmann; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

3.  Anderson-Fabry disease in Austria.

Authors:  Matthias Lorenz; Anna-Christina Hauser; Margot Püspök-Schwarz; Peter Kotanko; Ingrid Arias; Herbert Zodl; Reinhard Kramar; Eduard Paschke; Till Voigtländer; Gere Sunder-Plassmann
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

4.  Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism.

Authors:  F Monzani; N Caraccio; G Siciliano; L Manca; L Murri; E Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

5.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

6.  A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism.

Authors:  E Nyström; K Caidahl; G Fager; C Wikkelsö; P A Lundberg; G Lindstedt
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

7.  Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

Authors:  R Schiffmann; J B Kopp; H A Austin; S Sabnis; D F Moore; T Weibel; J E Balow; R O Brady
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

8.  Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy.

Authors:  F Monzani; N Caraccio; P Del Guerra; A Casolaro; E Ferrannini
Journal:  Clin Endocrinol (Oxf)       Date:  1999-08       Impact factor: 3.478

9.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Authors:  C Meier; J J Staub; C B Roth; M Guglielmetti; M Kunz; A R Miserez; J Drewe; P Huber; R Herzog; B Müller
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

10.  Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.

Authors:  F Monzani; N Caraccio; M Kozàkowà; A Dardano; F Vittone; A Virdis; S Taddei; C Palombo; E Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

View more
  7 in total

1.  A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing.

Authors:  H P Gaide Chevronnay; V Janssens; P Van Der Smissen; X H Liao; Y Abid; N Nevo; C Antignac; S Refetoff; S Cherqui; C E Pierreux; P J Courtoy
Journal:  Endocrinology       Date:  2015-03-26       Impact factor: 4.736

Review 2.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

Review 3.  Endocrine manifestations related to inherited metabolic diseases in adults.

Authors:  Marie-Christine Vantyghem; Dries Dobbelaere; Karine Mention; Jean-Louis Wemeau; Jean-Marie Saudubray; Claire Douillard
Journal:  Orphanet J Rare Dis       Date:  2012-01-28       Impact factor: 4.123

4.  Hypothyroidism in late-onset Pompe disease.

Authors:  Joseph Schneider; Lynn A Burmeister; Kyle Rudser; Chester B Whitley; Jeanine Jarnes Utz
Journal:  Mol Genet Metab Rep       Date:  2016-07-01

5.  Endocrine disorders in patients with Fabry disease: insights from a reference centre prospective study.

Authors:  Christina Bothou; Felix Beuschlein; Albina Nowak
Journal:  Endocrine       Date:  2021-11-09       Impact factor: 3.633

Review 6.  A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review.

Authors:  Avinaash Maharaj; Ruth Kwong; Jack Williams; Christopher Smith; Helen Storr; Ruth Krone; Debora Braslavsky; Maria Clemente; Nanik Ram; Indraneel Banerjee; Semra Çetinkaya; Federica Buonocore; Tülay Güran; John C Achermann; Louise Metherell; Rathi Prasad
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

7.  Fabry disease superimposed on overt autoimmune hypothyroidism.

Authors:  Noriyuki Katsumata; Akira Ishiguro; Hiroshi Watanabe
Journal:  Clin Pediatr Endocrinol       Date:  2011-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.